JP2004513638A - ベクター - Google Patents

ベクター Download PDF

Info

Publication number
JP2004513638A
JP2004513638A JP2002542098A JP2002542098A JP2004513638A JP 2004513638 A JP2004513638 A JP 2004513638A JP 2002542098 A JP2002542098 A JP 2002542098A JP 2002542098 A JP2002542098 A JP 2002542098A JP 2004513638 A JP2004513638 A JP 2004513638A
Authority
JP
Japan
Prior art keywords
adenovirus
component
vector
expression
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002542098A
Other languages
English (en)
Japanese (ja)
Inventor
ヨハン・ヴィンクラー
ケネス・ロバート・ブンデル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0027501.6A external-priority patent/GB0027501D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of JP2004513638A publication Critical patent/JP2004513638A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2002542098A 2000-11-10 2001-11-06 ベクター Pending JP2004513638A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0027501.6A GB0027501D0 (en) 2000-11-10 2000-11-10 Vector
US25292700P 2000-11-27 2000-11-27
PCT/GB2001/004916 WO2002038783A1 (fr) 2000-11-10 2001-11-06 Vecteur

Publications (1)

Publication Number Publication Date
JP2004513638A true JP2004513638A (ja) 2004-05-13

Family

ID=26245268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002542098A Pending JP2004513638A (ja) 2000-11-10 2001-11-06 ベクター

Country Status (4)

Country Link
EP (1) EP1337656A1 (fr)
JP (1) JP2004513638A (fr)
AU (1) AU2002212507A1 (fr)
WO (1) WO2002038783A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727689A1 (fr) * 1994-12-01 1996-06-07 Transgene Sa Nouveau procede de preparation d'un vecteur viral
DK0937098T3 (da) * 1995-06-07 2002-12-02 Invitrogen Corp Rekombinatorisk kloning under anvendelse af gensplejsede rekombinationssites
US5922576A (en) * 1998-02-27 1999-07-13 The John Hopkins University Simplified system for generating recombinant adenoviruses
AU765093B2 (en) * 1999-03-05 2003-09-11 Advec, Inc. Enhanced system for construction of adenovirus vectors

Also Published As

Publication number Publication date
EP1337656A1 (fr) 2003-08-27
WO2002038783A1 (fr) 2002-05-16
AU2002212507A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
US5922576A (en) Simplified system for generating recombinant adenoviruses
JP7104994B2 (ja) アデノウイルスおよび対応するプラスミドの作製方法
US10167485B2 (en) Production of viral vectors
AU6346900A (en) Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
US6838285B2 (en) Site specific recombinase based method for producing adenoviral vectors
Barkner et al. Expression of dihydrololate reductase, and of the adjacent Elb region, in an Ad5-dihydrofolate reductase recombinant virus
Choi et al. AdHTS: a high-throughput system for generating recombinant adenoviruses
CN113957089B (zh) 一种筛选调控序列的载体体系和应用
JP7407099B2 (ja) 大きな核酸をクローニングするためのアデノウイルスベクターを作製する手段
JP2004513638A (ja) ベクター
US20040048381A1 (en) Vector
KR20190115717A (ko) 동물 세포에서 표적 ｄｎａ의 메틸화 감소와 표적 유전자의 발현 증가를 위한 조성물, 키트, 및 이를 이용한 방법
EP1218527A2 (fr) Vecteurs adenoviraux de traitement de maladies
JP2023543291A (ja) ＣＲＩＳＰＲ／ＣＡＳ媒介ｉｎ ｖｉｖｏ末端分離による組換えアデノウイルスのレスキュー
JP5800176B2 (ja) 哺乳動物細胞内で目的遺伝子の増幅構造を制御し、高発現させる方法
US9506082B2 (en) Eukaryotic expression vectors resistant to transgene silencing
CA2522624C (fr) Nouveau cosmide vecteur
CN117448284A (zh) 一种稳定传代的表达egfp的重组坦布苏病毒及构建方法
Long et al. Construction of a multi-functional helper-dependent adenovirus based system for cancer gene therapy
Fishbein et al. 879. Transduction Enhancement by the Adenovirus/Polymer Complexes Derivatized with Protein Transduction Domain Peptides
AU2005209653A1 (en) Adenoviral vectors for treating disease
AU2002327645A1 (en) Site-specific recombinase based method for producing adenoviral vectors